Low-dose continuous infusion 5-fluorouracil combined with weekly leucovorin, nab-paclitaxel, oxaliplatin, and bevacizumab for patients with advanced pancreatic cancer: A pilot study. Background: ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback